IOS Press is pleased to announce the publication of a landmark study in which both traditional and innovative scientometric approaches have been employed to identify the top 100 Parkinson's disease (PD) investigators since 1985 and measure their scientific productivity as well as the impact of their contributions to the field. The article appears today in the inaugural issue of the Journal of Parkinson's Disease.
This milestone analysis has been conducted by Aaron A. Sorensen, a noted expert in the fields of scientometrics and bibliometrics and currently Clinical Research Industry Specialist at GE Healthcare, and David Weedon, a Publishing Consultant based in London, formerly Managing Director of Biology Reports Ltd. While the study employs traditional bibliometric techniques to rank investigators, the authors have utilized innovative metrics to complement traditional tools that do not always give a full picture of the impact of a researcher's work.
"The number of citations an article receives is widely accepted as a measure of its impact," commented Sorensen and Weedon. "There has not, however, been a broad analysis of the PD research literature to assess, in a comprehensive manner, the impact and productivity of the top investigators, which this study aims to provide. It is interesting to note that approximately half the names in the Top 20 for the last decade are names that did not appear in the Top 20 for the last 25 years."
The authors have compiled a list of the 100 most cited PD researchers since 1985. The top 20 researchers identified are:
- Lees, Andrew J, University College London
- Marsden, C David, University College London
- Agid, Yves, Pitié - Salpêtrière University Hospital, Paris
- Lang, Anthony E, Toronto Western Research Institute
- Olanow, C Warren, Mount Sinai School of Medicine, New York, NY
- Brooks, David J, Imperial College London
- Jenner, Peter, King's College London
- Mizuno, Yoshikuni, Juntendo University School of Medicine, Tokyo
- Fahn, Stanley, Columbia University, New York, NY
- Benabid, Alim-Louis, Joseph Fourier University, Grenoble
- Goetz, Christopher G, Rush University Medical Center, Chicago, IL
- Quinn, Niall P, University College London
- Pollak, Pierre, Joseph Fourier University, Grenoble
- Hirsch, Etienne C, Pitié - Salpêtrière University Hospital, Paris
- Koller, William C, University of North Carolina, Chapel Hill, NC
- Lozano, Andres M, University of Toronto
- Riederer, Peter, Universität Wüzburg
- Jankovic, Joseph, Baylor College of Medicine, Houston, TX
- Daniel, Susan E, University College London
- Tanner, Caroline M, The Parkinson's Institute, Sunnyvale, CA
- Lang, Anthony E, Toronto Western Research Institute
- Farrer, Matthew, Mayo Clinic, Jacksonville, FL
- Lees, Andrew J, University College London
- Olanow, C Warren, Mount Sinai School of Medicine, New York, NY
- Singleton, Andrew, National Institute of Aging – NIH, Bethesda, MD
- Przedborski, Serge, Columbia University, New York, NY
- Wood, Nicholas W, University College London
- Pollak, Pierre, Joseph Fourier University, Grenoble
- Benabid, Alim-Louis, Joseph Fourier University, Grenoble
- Poewe, Werner, Innsbruck Medical University
- Jankovic, Joseph, Baylor College of Medicine, Houston, TX
- Fahn, Stanley, Columbia University, New York, NY
- Hardy, John, University College London
- Agid, Yves, Pitié - Salpêtrière University Hospital, Paris
- Lozano, Andres M, University of Toronto
- Albanese, Alberto, Universita Cattolica del Sacro Cuore, Milan
- Goetz, Christopher G, Rush University Medical Center, Chicago, IL
- Dawson, Ted M, Johns Hopkins University, Baltimore, MD
- Cookson, Mark R, National Institute on Aging – NIH, Bethesda, MD
- Maraganore, Demetrius M, Mayo Clinic – Minnesota, Rochester, MN
Parkinson's disease is the second most common neurodegenerative disorder, affecting 1% of the population over the age of 65. It is characterized by loss of brain cells (neurons) from the mid-brain which use the neurotransmitter dopamine to help control voluntary movements.
More information: Because of the importance of this study to the PD community, the Journal of Parkinson's Disease is making it freely available in electronic format at iospress.metapress.com/content … pw67251/fulltext.pdf
Provided by IOS Press